Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of insulin injection site and timing on postprandial glucose in type 2 diabetes mellitus
IRCT2017062134690N1Phase 3Completed
- Sponsor
- Agus Santosa
- Start
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Agus Santosa. Primary endpoint: Postprandial glucose control. Started May 2015; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT2017062134690N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017062134690N1.